Fighting Vision Loss: Vabysmo
PharmExec
SEPTEMBER 9, 2022
Use against pair of pathways could pave way for standout in stocked eye disease market.
fighting-vision-loss-vabysmo 
105 
Roche Canada and pCPA conclude talks for Vabysmo eye therapy
Pharmaceutical Technology
MAY 30, 2023
Roche Canada has successfully concluded talks with the pan-Canadian Pharmaceutical Alliance (pCPA) for Vabysmo (faricimab injection). Vabysmo is administered into the eye to treat patients with neovascular (wet) age-related macular degeneration (AMD) and diabetic macular oedema (DME).
Let's personalize your content